BIO News and Press, Bio-Rad Laboratories Inc. Class A

2026-06-22 18:04:44 ET Is your portfolio better served by a diagnostic equipment leader or a pharmaceutical research titan? Deciding between Bio-Rad Laboratories (NYSE:BIO) and Charles River Laboratories International (NYSE:CRL) requires weighing specialized equipment agains...

2026-06-03 12:41:59 ET Bio-Rad Laboratories, Inc. (BIO) Jefferies Global Healthcare Conference 2026 June 3, 2026 8:45 AM EDT... Read the full article on Seeking Alpha For further details see: Bio-Rad Laboratories, Inc. (BIO) Presents at Jefferies Global Healthcare Conference...

2026-06-01 10:10:27 ET More on Acadia Healthcare, Waystar, etc. Bio-Rad Laboratories, Inc. (BIO) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript Prestige Consumer Healthcare: Better Valuation, But Too Much Uncertainty To Buy Option Care H...

2026-05-25 07:15:04 ET from Wells Fargo issued a price target of $310.00 for BIO on 2026-05-25 09:06:56. The adjusted price target was set to $310.00. At the time of the announcement, BIO was trading at $287.74. The overall price target consensus is at $315.00 with high ...

2026-05-19 10:40:56 ET Bio-Rad Laboratories, Inc. (BIO) RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 8:30 AM EDT... Read the full article on Seeking Alpha For further details see: Bio-Rad Laboratories, Inc. (BIO) Presents at RBC Capital Markets Global H...

2026-05-18 06:20:26 ET More on markets S&P 500: The Topping Process Treasury Yields Are Testing The AI Equity Rally S&P 500 Snapshot: 7-Week Win Streak Survives Friday Slump Goldman Sachs warns AI-fueled market rally is becoming ‘one big trade&...

2026-05-17 23:37:44 ET More on Bio-Rad Laboratories, Inc., Sartorius Aktiengesellschaft Bio-Rad Laboratories, Inc. (BIO) Q1 2026 Earnings Call Transcript Sartorius Aktiengesellschaft 2026 Q1 - Results - Earnings Call Presentation Sartorius Aktiengesellschaft (SOAGY) ...

2026-05-14 18:15:03 ET from RBC Capital issued a price target of $320.00 for BIO on 2026-05-14 20:24:17. The adjusted price target was set to $320.00. At the time of the announcement, BIO was trading at $246.27. The overall price target consensus is at $312.50 with high ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: 2026 RBC Capital Markets Global Healthcare Conference Format: F...

2026-05-07 21:15:00 ET The following segment was excerpted from the Ariel Focus Fund ( ARFFX ) Q1 2026 Commentary. ... Read the full article on Seeking Alpha For further details see: Ariel Focus Fund Q1 2026 Performers And Detractors